CARE vs NEWT
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 23, 2026
CARE
NEWT
Investment Advisor Scores
NEWT
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CARE | NEWT | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 13.6612 | 5.3648 | NEWT |
| PEG Ratio | 0 | 3.2026 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 68.3% | 14.7% | CARE |
| Earnings Growth | 253.9% | -9.6% | CARE |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 59.8/100 | 61.7/100 | NEWT |
| Profit Margin | 44.9% | 16.1% | CARE |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CARE
NeutralMixed signals - no dominant trend phase, RSI 40
NEWT
NeutralMixed signals - no dominant trend phase, RSI 31
Fundamentals Snapshot
| Metric | CARE | NEWT |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 12.1 | 5.3 |
| Trailing P/E | 5.3 | 5.7 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.7% | 0.1% |
| Gross Margin | 1.0% | 0.9% |
| Operating Margin | 0.6% | 0.5% |
| EPS | 5.80 | 2.21 |
| Dividend Yield | 0.00% | 0.06% |